Indeed, as reviewed [28], immunomodulatory treatments like intravenous immunoglobulin (IVIg) have demonstrated a short term and modest effect on patients with polyneuropathy and anti-MAG antibodies and are not usually considered as a first-line treatment of this condition [29]. Here, MAG is linked to polyneuropathy.